SERMORELIN COMPOUND // ABOUT
About This Project
A single-drug monograph of the published sermorelin research — what the studies measured, and what the regulatory record actually says.
What this site is
Sermorelin Compound reads like a single-drug monograph: a plain-language digest of the peer-reviewed sermorelin research, laid out the way a formulary entry is — mechanism, studied doses, findings, and limits, each line cited to the trial behind it. The site supplies information and nothing else. It runs no pharmacy and fills no orders, keeps no clinicians on staff, and offers no diagnosis, prescription, or medical guidance of any kind.
The site is built as a research-reference console: a place to read the GHRH(1-29) mechanism, the pediatric and aging trials, the cognition and pharmacokinetic data, and the full regulatory record one screen at a time, with every quantitative claim mapped to a numbered source.
What 'compound' means here
The word "compound" in this domain refers to sermorelin as a research compound and to its status as a compounded preparation under the 503A framework — an editorial frame describing the molecule and its regulatory record. It is not a claim that this site compounds, prepares, or supplies anything. We hold no inventory, fill no prescriptions, and occupy no pharmacy counter. The name marks the subject we read about, not a service we offer.
Our editorial stance is deliberately literal: state the mechanism as the studies establish it, state the sermorelin FDA approval status exactly as the record shows it (approved, withdrawn for commercial reasons in 2008, now Category 1 under 503A), and mark the gap where anti-aging marketing outpaces the direct evidence.
How we handle the evidence
Every figure on this site is carried back to a specific study, listed on the references page with its DOI or PubMed identifier. Where the literature is strong — the pediatric height-velocity result, the aging-study reversal of GH and IGF-1 decline, the controlled cognition trial — we say so plainly. Where it is thin or contested — long-term anti-aging safety, general weight-loss claims, single computational findings — we mark the limit rather than paper over it. The aim is a sober, accurate readout that a careful reader can verify, not a promotional page.